{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:44:39Z","timestamp":1770500679372,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,9,1]],"date-time":"1985-09-01T00:00:00Z","timestamp":494380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[1985,9]]},"DOI":"10.1007\/bf01531497","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T02:07:23Z","timestamp":1113876443000},"page":"257-267","source":"Crossref","is-referenced-by-count":51,"title":["Pharmacological treatment of self-injurious behavior in mentally retarded persons"],"prefix":"10.1007","volume":"15","author":[{"given":"Nirbhay N.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Jane","family":"Millichamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"154","volume":"96","author":"W. C. Adamson","year":"1958","unstructured":"Adamson, W. C., Nellis, B. P., Runge, C., Cleland, C., & Killian, E. (1958). Use of tranquilizers for mentally deficient patients.Journal of Diseases of Children, 96, 154?164.","journal-title":"Journal of Diseases of Children"},{"key":"CR2","first-page":"455","volume-title":"Treatment issues and innovations in mental retardation","author":"M. G. Aman","year":"1983","unstructured":"Aman, M. G. (1983). Psychoactive drugs in mental retardation. In J. L. Matson & F. Andrasik (Eds.),Treatment issues and innovations in mental retardation (pp. 455?513). New York: Plenum Press."},{"key":"CR3","volume-title":"Advances in human psychopharmacology (Vol. 3)","author":"M. G. Aman","year":"1984","unstructured":"Aman, M. G. (1984). Drugs and learning in mentally retarded persons. In G. D. Burrows & J. S. Werry (Eds.),Advances in human psychopharmacology (Vol. 3). Greenwich, Connecticut: JAI Press."},{"key":"CR4","first-page":"331","volume":"84","author":"M. G. Aman","year":"1980","unstructured":"Aman, M. G., & Singh, N. N. (1980). The usefulness of thioridazine for treating childhood disorders: Fact or folklore?American Journal of Mental Deficiency, 84, 331?338.","journal-title":"American Journal of Mental Deficiency"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0270-3092(82)80002-7","volume":"3","author":"M. G. Aman","year":"1982","unstructured":"Aman, M. G., & Singh, N. N. (1982). Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior.Applied Research in Mental Retardation, 3, 345?348.","journal-title":"Applied Research in Mental Retardation"},{"key":"CR6","first-page":"317","volume-title":"Handbook of mental retardation","author":"M. G. Aman","year":"1983","unstructured":"Aman, M. G., & Singh, N. N. (1983). Pharmacological intervention. In J. L. Matson & J. A. Mulick (Eds.),Handbook of mental retardation (pp. 317?337). Elmsford, New York: Pergamon Press."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-0028-1091644","volume":"7","author":"L. T. Anderson","year":"1976","unstructured":"Anderson, L. T., Hermann, L., & Dancis, J. (1976). The effects of L-5-hydroxytryptophan on self-mutilation in Lesch-Nyhan disease: A negative report.Neuropaediatrie, 7, 439?442.","journal-title":"Neuropaediatrie"},{"key":"CR8","volume-title":"Psychopharmacology: A generation of progress","author":"R. A. Baldessarini","year":"1978","unstructured":"Baldessarini, R. A., & Tansey, D. (1978). Tardive dyskinesia. In M. A. Lipton, A. DiMascio, & K. Killam (Eds.),Psychopharmacology: A generation of progress. New York: Raven Press."},{"key":"CR9","first-page":"57","volume":"18","author":"S. E. Breuning","year":"1982","unstructured":"Breuning, S. E. (1982). An applied dose-response curve of thioridazine use with the mentally retarded: Aggressive, self-stimulatory, intellectual, and workshop behaviors ? A preliminary report.Psychopharmacology Bulletin, 18, 57?59.","journal-title":"Psychopharmacology Bulletin"},{"key":"CR10","volume-title":"Drugs and mental retardation","author":"S. E. Breuning","year":"1982","unstructured":"Breuning, S. E., & Poling, A. D. (1982).Drugs and mental retardation. Springfield, Illinois: Charles C Thomas."},{"key":"CR11","first-page":"147","volume":"124","author":"H. W. Burke","year":"1968","unstructured":"Burke, H. W., & Menolascino, F. J. (1968). Haloperidol in emotionally disturbed mentally retarded individuals.American Journal of Psychiatry, 124, 147?149.","journal-title":"American Journal of Psychiatry"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF01537617","volume":"2","author":"M. Campbell","year":"1972","unstructured":"Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., & Koh, C. (1972). Lithium and chlorpromazine: A controlled crossover study of hyperactive severely disturbed young children.Journal of Autism and Childhood Schizophrenia, 2, 234?263.","journal-title":"Journal of Autism and Childhood Schizophrenia"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF01464036","volume":"7","author":"R. D. Ciaranello","year":"1976","unstructured":"Ciaranello, R. D., Anders, T. F., Barchas, J. D., Bergers, P. A., & Cann, H. M. (1976). The use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.Child Psychiatry and Human Development, 7, 127?133.","journal-title":"Child Psychiatry and Human Development"},{"key":"CR14","unstructured":"Cohen, M. N., & Sprague, R. L. (1977).Survey of drug usage in two midwestern institutions for the retarded. Paper presented at the Gatlinburg Conference on Research in Mental Retardation, Gatlinburg, Tennessee."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1192\/bjp.122.3.370","volume":"122","author":"A. J. Cooper","year":"1972","unstructured":"Cooper, A. J., & Fowlie, H. C. (1972). Control of gross self-mutilation with lithium carbonate.British Journal of Psychiatry, 122, 370?371.","journal-title":"British Journal of Psychiatry"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1192\/bjp.137.5.469","volume":"137","author":"P. G. Dale","year":"1980","unstructured":"Dale, P. G. (1980). Lithium therapy in aggressive mentally subnormal patients.British Journal of Psychiatry, 137, 469?474.","journal-title":"British Journal of Psychiatry"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0270-3092(83)80013-7","volume":"4","author":"P. W. Davidson","year":"1983","unstructured":"Davidson, P. W., Kleene, B. M., Carroll, M., & Rockowitz, R. J. (1983). Effects of naloxone on self-injurious behavior: A case study.Applied Research in Mental Retardation, 4, 1?4.","journal-title":"Applied Research in Mental Retardation"},{"key":"CR18","first-page":"359","volume-title":"Drugs and mental retardation","author":"V. J. Davis","year":"1982","unstructured":"Davis, V. J., Cullari, S., & Breuning, S. E. (1982). Drug use in community foster-group homes. In S. E. Breuning & A. D. Poling (Eds.),Drugs and mental retardation (pp. 359?376). Springfield, Illinois: Charles C Thomas."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01531370","volume":"12","author":"V. M. Durand","year":"1982","unstructured":"Durand, V. M. (1982). A behavioral\/pharmacological intervention for the treatment of severe selfinjurious behavior.Journal of Autism and Developmental Disorders, 12, 243?251.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"CR20","first-page":"588","volume":"85","author":"K. D. Gadow","year":"1981","unstructured":"Gadow, K. D., & Kalachnik, J. (1981). Prevalence and pattern of drug treatment for behavior and seizure disorders of TMR students.American Journal of Mental Deficiency, 85, 588?595.","journal-title":"American Journal of Mental Deficiency"},{"key":"CR21","first-page":"305","volume":"26","author":"M. Galambos","year":"1965","unstructured":"Galambos, M. (1965). Long-term clinical trial with diazepam on adult mentally retarded persons.Diseases of the Nervous System, 26, 305?309.","journal-title":"Diseases of the Nervous System"},{"key":"CR22","first-page":"856","volume":"15","author":"S. W. Grabowski","year":"1973","unstructured":"Grabowski, S. W. (1973). Safety and effectiveness of haloperidol for mentally retarded behaviorally disordered and hyperkinetic patients.Current Therapeutic Research, 15, 856?861.","journal-title":"Current Therapeutic Research"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0270-3092(80)90016-8","volume":"1","author":"C. T. Gualtieri","year":"1980","unstructured":"Gualtieri, C. T., & Hawk, B. (1980). Tardive dyskinesia and other drug-induced movement disorders among handicapped children and youth.Applied Research in Mental Retardation, 1, 55?69.","journal-title":"Applied Research in Mental Retardation"},{"key":"CR24","first-page":"292","volume":"78","author":"J. Haegeman","year":"1978","unstructured":"Haegeman, J., & Duyck, F. (1978). A retrospective evaluation of pipamperone (Dipiperon) in the treatment of behavioral deviations in severely mentally handicapped.Acta Psychiatrica Belgica, 78, 292?298.","journal-title":"Acta Psychiatrica Belgica"},{"key":"CR25","volume-title":"Single-subject research designs","author":"M. Hersen","year":"1976","unstructured":"Hersen, M., & Barlow, D. (1976).Single-subject research designs. New York: Pergamon Press."},{"key":"CR26","unstructured":"Hollis, J. H., & Meyers, C. E. (1982).Life threatening behavior: Analysis and intervention. Washington, D.C.: AAMD Monographs, No. 5."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/070674377301800507","volume":"18","author":"J. Lacny","year":"1973","unstructured":"Lacny, J. (1973). Mesordidazine in the case of disturbed mentally retarded patients.Canadian Psychiatric Association Journal, 18, 389?391.","journal-title":"Canadian Psychiatric Association Journal"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/070674376901400215","volume":"14","author":"L. J. Vann Le","year":"1969","unstructured":"Le Vann, L. J. (1969). Haloperidol in the treatment of behavioral disorders in children and adolescents.Canadian Psychiatric Association Journal, 14, 217?220.","journal-title":"Canadian Psychiatric Association Journal"},{"key":"CR29","first-page":"387","volume-title":"Psychiatric approaches to mental retardation","author":"R. S. Lipman","year":"1970","unstructured":"Lipman, R. S. (1970). The use of psychopharmacological agents in residential facilities for the retarded. In F. J. Menolascino (Ed.),Psychiatric approaches to mental retardation (pp. 387?398). New York: Basic Books."},{"key":"CR30","first-page":"261","volume-title":"Advances in learning and behavioral disabilities (Vol. 1","author":"R. S. Lipman","year":"1982","unstructured":"Lipman, R. S. (1982). Psychotropic drugs in mental retardation: The known and the unknown. In K. D. Gadow & I. Bialer (Eds.),Advances in learning and behavioral disabilities (Vol. 1, pp. 261?282), Greenwich, Connecticut: JAI Press."},{"key":"CR31","first-page":"229","volume":"60","author":"A. F. Llorente","year":"1969","unstructured":"Llorente, A. F. (1969). The management of behavior disorders with thioridazine in the mentally retarded.Journal of the Maine Medical Association, 60, 229?231.","journal-title":"Journal of the Maine Medical Association"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.125.1.110","volume":"125","author":"V. Micev","year":"1974","unstructured":"Micev, V., & Lynch, D. M. (1974). Effect of lithium on disturbed severely mentally retarded patients.British Journal of Psychiatry, 125, 110.","journal-title":"British Journal of Psychiatry"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-0028-1091647","volume":"6","author":"T. Mizuno","year":"1975","unstructured":"Mizuno, T., & Yugari, Y. (1975). Prophylactic effects of L-5-hydroxytryptophan on selfmutilation in the Lesch-Nyhan syndrome.Neuropaediatrie, 6, 13?23.","journal-title":"Neuropaediatrie"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0270-3092(80)90014-4","volume":"1","author":"W. L. Nyhan","year":"1980","unstructured":"Nyhan, W. L., Johnson, H. G., Kaufman, I. A., & Jones, K. (1980). Serotonergic approaches to the modification of behavior in the Lesch-Nyhan syndrome.Applied Research in Mental Retardation, 1, 25?40.","journal-title":"Applied Research in Mental Retardation"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2307\/1228421","volume":"31","author":"R. Plotkin","year":"1979","unstructured":"Plotkin, R., & Gill, K. R. (1979). Invisible mancles: Drugging mentally retarded people.Stanford Law Review, 31, 637?678.","journal-title":"Stanford Law Review"},{"key":"CR36","first-page":"163","volume":"23","author":"D. A. Primrose","year":"1979","unstructured":"Primrose, D. A. (1979). Treatment of self-injurious behavior with a gaba (gamma-amniobutyric acid) analogue.Journal of Mental Deficiency Research, 23, 163?173.","journal-title":"Journal of Mental Deficiency Research"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0270-3092(83)80014-9","volume":"4","author":"C. A. Sandman","year":"1983","unstructured":"Sandman, C. A., Datta, P. C., Barron, J., Hoehler, F. K., Williams, C., & Swanson, J. M. (1983). Naloxone attenuates self-abusive behavior in developmentally disabled clients clients.Applied Research in Mental Retardation, 4, 5?11.","journal-title":"Applied Research in Mental Retardation"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4615-7130-8_3","volume-title":"Handbook of behavior modification with the mentally retarded","author":"S. R. Schroeder","year":"1981","unstructured":"Schroeder, S. R., Schroeder, C. S., Rojahn, J., & Mulick, J. A. (1981). Self-injurious behavior: An analysis of behavior management techniques. In J. L. Matson & J. R. McCartney (Eds.),Handbook of behavior modification with the mentally retarded (pp. 61?115). New York: Plenum."},{"key":"CR39","first-page":"387","volume-title":"Advances in pediatrics (Vol. 28)","author":"N. N. Singh","year":"1981","unstructured":"Singh, N. N. (1981). Current trends in the treatment of self-injurious behavior. In L. A. Barnes (Ed.),Advances in pediatrics (Vol. 28), (pp. 387?398). Chicago: Year Book Medical Publishers."},{"key":"CR40","unstructured":"Singh, N. N. (1983).Using applied behavior analysis methodology to evaluate the effects of pharmacotherapy. Paper presented at the Behavior Analysis Symposium, New Zealand Psychological Society Conference, Auckland, New Zealand."},{"key":"CR41","first-page":"580","volume":"85","author":"N. N. Singh","year":"1981","unstructured":"Singh, N. N., Aman, M. G. (1981). Effects of thioridazine dosage on the behavior of severely mentally retarded persons.American Journal of Mental Deficiency, 85, 580?587.","journal-title":"American Journal of Mental Deficiency"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0270-3092(84)80028-4","volume":"5","author":"N. N. Singh","year":"1984","unstructured":"Singh, N. N., & Winton, A. S. W. (1984). Behavioral monitoring of pharmacological intervention for self-injury.Applied Research in Mental Retardation, 5, 161?170.","journal-title":"Applied Research in Mental Retardation"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005053-198103000-00007","volume":"169","author":"R. Sovner","year":"1981","unstructured":"Sovner, R., & Hurley, A. (1981). The management of chronic behavior disorders in mentally retarded adults with lithium carbonate.Journal of Nervous and Mental Disease, 169, 191?195.","journal-title":"Journal of Nervous and Mental Disease"},{"key":"CR44","first-page":"377","volume-title":"Drugs and mental retardation","author":"R. L. Sprague","year":"1982","unstructured":"Sprague, R. L. (1982). Litigation, legislation, and regulations. In S. Breunig & A. D. Poling (Eds.),Drugs and mental retardation (pp. 377?414). Springfield, Illinois: Charles C Thomas."},{"key":"CR45","first-page":"92","volume-title":"Mental retardation and developmental disabilities (Vol. 10)","author":"R. L. Sprague","year":"1978","unstructured":"Sprague, R. L., & Baxley, G. B. (1978). Drugs for behavior management with comment on some legal aspects. In J. Wortis (Ed.),Mental retardation and developmental disabilities (Vol. 10), (pp. 92?120). New York: Brunner\/Mazel."},{"key":"CR46","first-page":"142","volume-title":"International review of research in mental retardation (Vol. 5)","author":"R. L. Sprague","year":"1971","unstructured":"Sprague, R. L., & Werry, J. S. (1971). Methodology of psychopharmacological studies with the retarded. In N. R. Ellis (Ed.),International review of research in mental retardation (Vol. 5), (pp. 142?219). New York: Academic Press."},{"key":"CR47","first-page":"125","volume":"40","author":"J. Tu","year":"1979","unstructured":"Tu, J. (1979). A survey of psychotropic medication in mental retardation facilities.Journal of Clinical Psychiatry, 40, 125?129.","journal-title":"Journal of Clinical Psychiatry"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/070674377001500316","volume":"15","author":"W. A. Zaleski","year":"1970","unstructured":"Zaleski, W. A. (1970). A clinical evaluation of mesoridiazine in mentally retarded patients.Canadian Psychiatric Association Journal, 15, 319?322.","journal-title":"Canadian Psychiatric Association Journal"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01531497\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01531497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01531497\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01531497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T13:31:43Z","timestamp":1556890303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01531497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["BF01531497"],"URL":"https:\/\/doi.org\/10.1007\/bf01531497","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}